id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-P-1898-0004,FDA,FDA-2015-P-1898,"Letter from FDA CDER to Hyman, Phelps & McNamara PC",Other,Letter(s),2015-12-31T05:00:00Z,2015,12,2015-12-31T05:00:00Z,,2015-12-31T14:55:43Z,,0,0,0900006481ddee16
FDA-2015-P-1898-0003,FDA,FDA-2015-P-1898,"Determination That KYTRIL Granisetron Hydrochloride) Tablets, Equivalent 1 Milligram and 2 Milligram Base, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,Determinations,2015-12-28T05:00:00Z,2015,12,2015-12-28T05:00:00Z,,2015-12-28T14:45:44Z,2015-32496,0,0,0900006481dd3cba
FDA-2015-P-1898-0001,FDA,FDA-2015-P-1898,"Citizen Petition from Hyman, Phelps & McNamara, P.C.",Other,Citizen Petition,2015-05-28T04:00:00Z,2015,5,2015-05-28T04:00:00Z,,2024-11-07T23:23:59Z,,1,0,0900006481b08a16
FDA-2015-P-1898-0002,FDA,FDA-2015-P-1898,"Acknowledgement Letter from FDA DDM to Hyman, Phelps & McNamara, P.C.",Other,Acknowledgement Letter/Receipt,2015-05-28T04:00:00Z,2015,5,2015-05-28T04:00:00Z,,2015-05-28T19:05:12Z,,0,0,0900006481b09a13